Being one of the first to try something new isn't always easy, but the team at Arizona Arthritis & Rheumatology Associates, PC has shown their commitment to improving medication access for their patients and to ensuring the success of their dispensing program since day one. They continue to be a trailblazer in the field of rheumatology and we are thankful to have such a dream partner in Arizona Arthritis & Rheumatology Associates, PC! Hear directly from Dr. Nehad Soloman and Prakash Viswanathan regarding their experience with medically integrated dispensing and why it’s made a difference for their practice and patients.
House Rx’s Post
More Relevant Posts
-
"🌟 Enhance Your Understanding: Join Our Rheumatoid Arthritis Educational Session for Newly Diagnosed Patients! 🩺📚 Please share with your patients or anyone that would like to learn more. Arthritis and Rheumatology of Georgia Arthritis and Rheumatology of Georgia Emory University School of Medicine Mohammed Abufayyah Grady Health System Atlanta VA Medical Center Omar K. Darsey Butler Hayes Wilson Kelly Weselman #RAawareness #HealthEducation"
-
-
Thanks #KarenFacey for this kind reminder to update our chapter on PRP involvent in the second edition of the book on patient involvent in #HTA
Excited to announce that our 2023 update of the EULAR - European Alliance of Associations for Rheumatology recommendations for the involvement of patient research partners in rheumatology research has been published open access in Annals of the Rheumatic Diseases... with 9 patient co-authors! Now the implementation phase begins to inform, educate, and empower the whole rheumatology community. 🔗 https://lnkd.in/ecbdgzth Maarten de Wit, Krystel Aouad, Muriel Elhai, Diego Benavent Nuñez, Heidi Bertheussen, Steven Blackburn, Peter Böhm, Catia Duarte, Marie Falahee, Susanne Karlfeldt, Uta Kiltz, Elsa Mateus, Dawn Richards, Javier Rodríguez-Carrio, Joachim Sagen, Russka Shumnalieva, MD, PhD, MPH, Simon Stones, Sander Tas, William Tillett, Ana Vieira, Tanita-Christina Wilhelmer, Codruta Flip, Jette Primdahl, Paul Studenic, Laure Gossec.
-
-
Now available! NEW Rheum2Learn 2.0 module—Rheumatoid Arthritis. This complimentary Rheum2Learn 2.0 activity provides fundamental rheumatology education and includes 3 clinical cases. Explore → https://acr.tw/3qy7i3Q
-
-
Will you be at the American Rheumatology Network's fall summit in Tuscon, AZ this week? Visit SamaCare at booth 16 to learn more about how we help rheumatology practices save staff time, expedite authorization turnaround, and reduce friction caused by the prior authorization process. #ARNfallsummit #rheumatology #priorauthorization
-
-
SENIOR DIRECTOR OF STRATEGIC PARTNERSHIPS/ PUBLIC POLICY ADVOCATE -- Donor Relations | Program Management | Campaign Management | Media Relations | Relationship Building | Budgets | National Event Planning
These fact sheets may help increase awareness and knowledge about vasculitis. One way that you can help is by sharing them with your primary doctor. Anyone can do that, whether you have vasculitis or not! #vasculitis #autoimmune #rarediseaseday
Newly diagnosed with ANCA-associated vasculitis? Share these new patient-friendly facts sheets and treatment recommendations with your doctor! These fact sheets are based on the ACR/VF (American College of Rheumatology/Vasculitis Foundation) Guidelines, which were developed by a group of doctors and patients based on research studies. The goal? To help you get the best care possible. Check out the fact sheets: https://lnkd.in/gXPH7gDT
-
-
Now available! NEW Rheum2Learn 2.0 modules—Systemic Sclerosis and Sjögren’s Disease. These complimentary Rheum2Learn 2.0 activities provide fundamental rheumatology education and include 3 clinical cases. Explore → https://acr.tw/47lLGHQ
-
-
Clinical Trial Spotlight - Psoriatic Arthritis (link below) https://lnkd.in/gT4n5cjc 🌟 Exciting News for Psoriatic Arthritis Warriors! 🌟 Are you or someone you know living with Psoriatic Arthritis? We have some fantastic news to share! 🔬 Spotlight on A Clinical Trial for Psoriatic Arthritis 🔬 You can be a part of this groundbreaking journey towards a better quality of life! 💪 Join the Fight Against Psoriatic Arthritis 💪 By participating in our clinical trial, you'll have the opportunity to: ✨ Access the latest treatments. 🌍 Contribute to scientific advancements. 👥 Connect with a supportive community. 📋 Play a vital role in improving Psoriatic Arthritis care. Ready to make a difference? Click on the link above to learn more and see if you qualify! Together, we can paint a brighter future for those battling Psoriatic Arthritis. 🎨💙 #PsoriaticArthritis #ClinicalTrial #MedicalResearch #HopeForACure #JoinTheFight
-
-
Now available! NEW Rheum2Learn 2.0 modules—Systemic Sclerosis and Sjögren’s Disease. These complimentary Rheum2Learn 2.0 activities provide fundamental rheumatology education and include 3 clinical cases. Explore → https://acr.tw/47lLGHQ
-
-
Worldwide Vice President, Specialty Ophthalmology TA, Global Commercial Strategy Organization
At Johnson & Johnson Innovative Medicine, we dare to envision a better future for patients living with inherited retinal diseases (IRDs). Take XLRP (X-linked retinitis pigmentosa) for example, an IRD that typically starts in adolescence and results in permanent blindness by the age of 45. This condition significantly impacts how patients navigate their daily life, from work to hobbies to social activities, and everything in between. Through potentially groundbreaking treatment innovation, we’re committed to restoring and preserving vision – and improving quality of life – among all those living with IRDs. But we can’t do so without understanding their individual experiences, including their needs, goals, and challenges. Our Retina team is proud to work alongside a number of advocacy organizations to engage directly with patients with IRDs and get a glimpse of the world from their perspective, listening and learning from each of their unique experiences. Together, we stand firm in our commitment to transform the lives of those living with IRDs – never settling until their unmet needs are addressed. To learn more about our progress in retinal disease innovation, check out the below: bit.ly/JNJRetina #JNJRetina
-